Search Orphan Drug Designations and Approvals
-
| Generic Name: | autologous T cells transduced with lentivirus to express a fully human anti-CD19 single chain variable fragment |
|---|---|
| Date Designated: | 03/19/2024 |
| Orphan Designation: | Treatment of Systemic Sclerosis |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Cabaletta Bio, Inc. 2929 Arch Street, Suite 600 Philadelphia, Pennsylvania 19104 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







